Legislation watch

Search all years.

2021 House Bill 4352: Impose more prescription drug marketing rules

Public Act 13 of 2022

Introduced by Rep. Sue Allor (R) on February 24, 2021
To prohibit pharmacies or a pharmacists from entering a contract that forbids their telling customers the current selling price of other brand name or generic versions of a drug, or interchangeable biological drug products. The bill would also let pharmacists provide certain price information without having to be asked.   Official Text and Analysis.
Referred to the House Health Policy Committee on February 24, 2021
Reported in the House on March 11, 2021
Without amendment and with the recommendation that the bill pass.
Received in the Senate on March 25, 2021
Referred to the Senate Health Policy and Human Services Committee on March 25, 2021
Reported in the Senate on February 1, 2022
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Received in the House on February 16, 2022
To concur with the Senate-passed version of the bill.
Signed by Gov. Gretchen Whitmer on February 23, 2022